Volume 19, Number 3—March 2013
CME ACTIVITY - Research
Clinical and Therapeutic Features of Pulmonary Nontuberculous Mycobacterial Disease, Rio de Janeiro, Brazil
Karla Gripp Couto de Mello, Fernanda C.Q. Mello, Liamar Borga, Valeria Rolla, Rafael S. Duarte, Elizabeth P. Sampaio, Steven M. Holland, D. Rebecca Prevots, and Margareth P. Dalcolmo
Table 1
Demographic and clinical features for patients with PNTM, Rio de Janeiro, Brazil, 1993– 2011*
| Characteristic | No. (%) patients |
|---|---|
| Male sex | 108 (62.1) |
| Age, median y (range) |
55 (24–86)† |
| Past or current smoker‡ |
95 (62.1) |
| Clinical findings | |
| Respiratory symptoms only | 106 (60.9) |
| Fever and weight loss | 15 (8.6) |
| Respiratory and systemic symptoms
(fever, weight loss) |
53 (30.5) |
| Previous TB treatment | |
| Treated previously for TB | 101 (58) |
| Referred while being treated for TB |
80 (79) |
| Radiology results (lesion type) | |
| Cavitary disease | 118 (67.8) |
| Fibronodular |
56 (32.2) |
| Median duration of treatment, mo (range) |
19 (2–36)† |
| ATS microbiologic criteria | |
| 1 positive sputum culture | 47 (27) |
| >2 positive sputum cultures |
101 1 (58) |
| Bronchoalveolar lavage | 24 (13.8) |
| Lung biopsy | 2 (1.1)) |
*PNTM, pulmonary nontuberculous mycobacterial disease; TB, tuberculosis; ATS, American Thoracic Society.
†Data are as indicated in the left column.
‡Smoking data were missing for 21 patients.
Page created: February 13, 2013
Page updated: February 22, 2013
Page reviewed: February 22, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.